Characterizing interactions between the cellular HIV-1 integration cofactor, LEDGF/p75 with chromatin and HIV-1 integrase
Year: 2013
Type: article
Abstract: Continuous emergence of HIV-1 phenotypes resistant to currently available therapies requires the need for development of new drugs with novel targets to prevent HIV-1 replication.Integration is an essential step in the life cycle of HIV-1 allowing for the stable integration of the viral genome into its host genome.The viral enzyme integrase (IN) catalyzes 3'-viral cDNA processing and DNA strand transfer reactions leading to the integration of the viral cDNA into the host DNA.HIV-1 IN is a promising therapeutic target due to the lack of a cellular counterpart.The first approved HIV-1 IN inhibitor specifically targets the IN:viral Mamuka Kvaratskhelia, for his mentorship, continuous encouragement, and guidance throughout my graduate studies.Second, I would like to thank each of my Committee members for serving on both my Candidacy and Dissertation/Defense committees.I would like to thank all the members of the Kvaratskhelia lab, including my advisor, for not only their technical support, but friendship over the past six years.Finally, I would like to thank my husband, Jason, for his endless support and for believing in me and encouraging me always.
Author: Jocelyn O. Eidahl
Institution: The Ohio State University
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2518894899
